HF 3922 Minnesota House · 2025-2026 Regular Session

Fair pricing in community pharmacy reimbursement required.

This bill requires community pharmacies in Minnesota to receive reimbursement for prescription drugs that is at least equal to the National Average Drug Acquisition Cost or Wholesale Acquisition Cost, plus a professional dispensing fee adjusted for inflation and operational costs. It directly affects pharmacy benefit managers, managed care organizations, and community pharmacies by prohibiting below-cost reimbursements, banning negative adjustments like transaction fees, and ensuring PBM-owned pharmacies cannot receive higher rates than independent community pharmacies for the same prescriptions. The law also excludes federal 340B program participants from these reimbursement requirements, allowing them to follow existing federal and state rules instead.
Bill status in committee 1 of 4 stages cleared
Introduction
Mar 2026
Committee Review
Floor Vote
Governor
Introduced Mar 2, 2026 Last action Apr 13, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
3
Key actions
0
Committee
0
Mar 2, 2026
Introduced
Introduction and first reading, referred to Health Finance and Policy
lower
1 primary · 4 co-sponsors

Sponsors